Page last updated: 2024-12-08

5-hydroxypyrazinoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-hydroxypyrazinoic acid: metabolite of pyrazinamide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161825
CHEMBL ID5171056
SCHEMBL ID241781
MeSH IDM0155049

Synonyms (45)

Synonym
EN300-29829
5-oxo-4,5-dihydropyrazine-2-carboxylic acid
HY-76210
BB 0260258
34604-60-9
5-hydroxypyrazine-2-carboxylic acid
5-hydroxy-2-pyrazinecarboxylic acid, >=96.0% (t)
STK503412
5-hydroxypyrazinoic acid
6-oxo-1h-pyrazine-3-carboxylic acid
AKOS000121905
4,5-dihydro-pyrazine-2-carboxylic acid
A6084
5-hydropyrazine-2-carboxylicacid
m2v0dp3enp ,
pyrazinecarboxylic acid, 4,5-dihydro-5-oxo-
unii-m2v0dp3enp
5-hydroxy-pyrazine-2-carboxylic acid
5-hydroxy-2-pyrazinecarboxylic acid
AM62707
2-pyrazinecarboxylic acid, 4,5-dihydro-5-oxo-
AKOS005171548
FT-0600247
PB32161
CS-0876
SCHEMBL241781
2-carboxy-5-hydroxy-pyrazine
CGQFCIHUUCMACC-UHFFFAOYSA-N
5-oxo-4,5-dihydro-pyrazine-2-carboxylic acid
2-hydroxy-5-pyrazinecarboxylic acid
5-hydroxypyrazine-3-carboxylic acid
mfcd00190599
TS-00040
Q-103325
DS-0397
F8881-7682
DTXSID40188179
AC-8941
CHEMBL5171056
4,5-dihydro-5-oxo-2-pyrazinecarboxylic acid
BCP23303
Q63392308
5-oxo-4,5-dihydropyrazine-2-carboxylicacid
PD012196
SY008215

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The method was applied to assess the comparative bioavailability of a 500mg PZA test and reference formulation in healthy subjects."( An improved LC-MS/MS method for the simultaneous determination of pyrazinamide, pyrazinoic acid and 5-hydroxy pyrazinoic acid in human plasma for a pharmacokinetic study.
Sanyal, M; Shah, JV; Shah, PA; Sharma, P; Shrivastav, PS, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1848086Antimycobacterial activity against Mycobacterium bovis BCG Pasteur ATCC35734 assessed as inhibition of bacterial growth incubated for 5 days by broth microdilution method2022Bioorganic & medicinal chemistry, 11-15, Volume: 74Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's3 (42.86)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]